TDTherese Scott Duncan

Therese Scott Duncan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Therese Scott Duncan has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is all knowledge, good knowledge?: Multinational Patient Survey on AI-Generated Prognostic Insights and Actionability for Parkinson’s Disease (Preprint)

    by Jamie Linnea Luckhaus, Anna Kharko, Therese Scott Duncan, Charlotte Blease, David M. Lyreskog, Margherita Fabbri, Monica Kurtis, Stelios Hadjidimitriou, John Zaras, Maria Hägglund, et al.

    BACKGROUND Predictive artificial intelligence (AI) is rapidly emerging in Parkinson's disease (PD) management, yet patient perspectives remain underexplored. Actionability is a key ethical consideration in prognostic disclosure. Understanding how people with PD (PwP) value and define actionable AI-generated prognostic information is essential for patient-centered design and implementation. OBJECTIVE This study aims to examine PwP’s preferences for AI-based prognostic information and explore how actionable insights are perceived and valued. METHODS In this convergent mixed-methods study, 149 PwP completed an online survey distributed through international patient networks between April and November 2025. Quantitative data were analysed using descriptive and inferential statistics, and free-text responses underwent qualitative content analysis. RESULTS Most expressed interest in knowing their motor prognosis (71%) and milestones (74%). Nearly half (47%) would only want feedback they can act upon. There was a significant association between education level and interest in knowing which factors may influence one’s prognosis (χ²(2)=6.69, p=.04), and between time since diagnosis and only wanting actionable insights (χ²(2)=7.38, p=.02). The meaning of actionability varied between individuals, including being described as the ability to influence disease progression, facilitating preparation, and as the credibility and personal applicability of insights. For some, actionability was necessary for wanting prognostic information, while for others information was valued regardless. CONCLUSIONS Respondents valued prognostic information beyond traditional intervention-focused definitions of actionability, though substantial individual variation remained. These findings support an individualized approach to communicating prognostic information, whereby healthcare professionals regularly assess and respond to patients' evolving preferences and informational needs throughout the disease course. CLINICALTRIAL N/A

  • Open Access

    Beyond self-management: introducing meta-selfcare as a framework for developing practical wisdom in chronic and long-term conditions (Preprint)

    by Sara Riggare, Kwanele Asante, Tamás Bereczky, Eva Dieker, Matthew Jackman, Nikhil Jayswal, Leonora Mujkic, Dawn P. Richards, Rita Schriemer, Therese Scott Duncan, et al.

    UNSTRUCTURED People living with chronic or long-term conditions typically spend only a few hours per year in direct contact with clinical care providers and over eight thousand hours managing their conditions independently. The scientific frameworks developed to understand this self-directed practice, primarily the literature on self-care and self-management, describe the tasks and practices involved in managing a condition, but not the deeper process by which people develop, over time, the knowledge, skills, and understanding needed to live well with it. We introduce the concept of meta-selfcare, defined as the process by which a person living with chronic or long-term conditions, individually and together with others, develops the knowledge, skills, and understanding needed to live what they themselves consider a worthwhile life in the presence of illness and/or disability and the varying limitations this may entail. Drawing on first-person accounts from co-authors living with a range of conditions, including Parkinson's disease, Systemic Sclerosis, chronic migraine, bowel disease, congestive heart failure, functional neurological disorder, HIV, lymphedema, plantar fasciitis, rheumatoid arthritis, and bipolar, we show that meta-selfcare is a real, recognizable, and meaningful process across conditions, contexts, and life trajectories. Naming this process has three consequences: it makes visible a form of patient knowledge that existing frameworks render invisible; it opens a research agenda for studying how patient knowledge develops and how health systems can support that development; and it creates the conditions for patient-led inquiry into a process that patients are uniquely positioned to investigate. Meta-selfcare is not new, people living with chronic conditions have been doing this for as long as they have lived with their conditions. What is new is the name.

  • Open Access

    Nationwide Digital Integrated Care Plan for Coordinated Health and Social Services – An Estonian Example

    by Anna Dudkina, Kadi Lubi, Katrin Gross-Paju, Therese Scott Duncan, Peeter Ross

    Ageing populations and multimorbidity highlight the limitations of siloed, disease-centered services. Despite Estonia’s highly digitalized healthcare system, integration between health and social care remains challenging, leaving individuals with complex needs without sufficient support. Based on international experience, the Estonian context, and multi-stakeholder focus groups, we identified key challenges and opportunities for implementing a consent-aware, interoperable Digital Integrated Care Plan (DICP). A DICP can enable shared understanding among professionals and ensure continuity of care across hospitals, primary care, and social services.

  • Open Access

    Adoption and Use of Proxy Online Record Access in Sweden – A Retrospective Analysis

    by Maria Hägglund, Anna Kharko, Sara Riggare, Charlotte Blease, Josefin Hagström, Therese Scott Duncan

    Patients’ online record access (ORA) enables patients to involve their family caregivers in care management by sharing health information, either through proxy access functionality or informally. In this study, we explore the adoption and use of proxy ORA in Sweden from Feb 2013 until June 2018 when the function was terminated, using publicly available usage statistics. In total, proxy access was shared 13 103 times in this period, and 7 917 of those shares were accepted. While adoption was slow to begin with, it increased over time and in total a proxy accessed a shared record 145 393 times. Although the available data has limitations, and further research is needed on the demographics of both patients and proxies, this study indicates there is a need for proxy ORA in Sweden.

  • Open Access

    Comparing Stakeholders’ Perspectives on Parkinson Disease Management and Digital Technologies: Exploratory International Survey

    by Jamie Linnea Luckhaus, Anna Kharko, Charlotte Blease, Maria-Luisa Almarcha-Menargues, Natalia Del Campo, Sofia Balula Dias, Beatriz Alves, Björn H Falkenburger, Leontios Hadjileontiadis, Maria Hägglund, et al.

    Background: Parkinson disease (PD) is a progressive neurodegenerative disorder that poses complex challenges for persons with PD, informal caregivers, and health care professionals. With growing interest in digital and predictive artificial intelligence (AI) tools for disease management, understanding the needs and digital readiness of these stakeholder groups is crucial. Objective: This work aims to (1) identify digital practices for PD management among persons with PD, at-risk individuals, caregivers, and health care professionals; (2) compare these practices across groups; (3) explore stakeholder desires for AI-based tools; and (4) assess alignments and gaps to inform tailored AI solutions. Methods: An anonymous cross-sectional online survey of an exploratory nature was distributed (from December 2024 to October 2025) in 5 languages and completed by 255 respondents. Descriptive statistics summarized responses to 41 questions, including stakeholder-specific items. χ 2 tests were performed to examine stakeholder differences in desired AI features. Results: Interest in predictive AI was high across stakeholder groups. Symptom tracking was the most desired feature (selected by more than 76% of the respondents), and personalized treatment recommendations came second for both persons with PD and health care professionals; however, stakeholder priorities diverged in other areas. Health care professionals rated improving patient and informal caregiver engagement as significantly more important than persons with PD did, χ 2 1 (n=205)=34.78, P <.001, and Cramer V=0.41. Despite considerable interest, the reported use of digital tools was limited, as most persons with PD did not use symptom-tracking apps or wearables, nor were they currently monitoring their condition, although many expressed intentions to begin. Conclusions: While predictive AI tools were viewed positively across groups, there were significant gaps in stakeholder preferences, highlighting the importance of tailored, context-aware design. Early diagnosis was not prioritized by persons with PD or health care professionals, likely reflecting the complexity of diagnosing PD in the absence of disease-modifying therapies. Coupled with the emphasis placed on preventive lifestyle guidance by persons with PD and those at risk, this highlights the importance of actionability in AI-based monitoring and prediction. Such actionability may also enhance perceived relevance and uptake, given that reported interest in digital health tools and self-tracking exceeded actual use. These findings offer early-stage insight to guide the development of future AI-based solutions for PD.

  • Open Access

    “ChatGPT knows my Parkinson's”: Perspectives of people with Parkinson's disease on use of generative AI

    by Jamie Linnea Luckhaus, Anna Kharko, Therese Scott Duncan, Sara Riggare, Maria Hägglund, Charlotte Blease

    Patients’ use of generative AI (GenAI) independently from healthcare is increasing across diseases. Little is known about its use among people with Parkinson's disease (PwP). This exploratory convenience-sample, mixed-methods online survey (n = 149, 19 countries) explored PwP's use of GenAI. Among our respondents, 65% had used GenAI, of which 40% had used it for disease-specific inquiries. Qualitative analysis identified informational, interpretive, and preparational uses of GenAI. As PwP increasingly bring AI-assisted data to consultations, clinicians must now actively engage in discussions about these tools, to support shared decision-making, safety and transparency.


  • Open Access

    Comparing Stakeholders’ Perspectives on Parkinson’s Disease Management and Digital Technologies: An Exploratory International Survey (Preprint)

    by Jamie Linnea Luckhaus, Anna Kharko, Charlotte Blease, Maria-Luisa Almarcha-Menargues, Natalia Del Campo, Sofia Balula Dias, Beatriz Alves, Björn H Falkenburger, Leontios Hadjileontiadis, Maria Hägglund, et al.

    BACKGROUND Parkinson’s disease (PD) is a progressive neurodegenerative disorder that poses complex challenges for persons with Parkinson’s (PwP), informal caregivers, and healthcare professionals. With growing interest in digital and predictive Artificial Intelligence (AI) tools for disease management, understanding the needs and digital readiness of these stakeholder groups is crucial. OBJECTIVE This work aims to (1) identify digital practices for PD management among PwP, at‑risk individuals, caregivers, and healthcare professionals; (2) compare these practices across groups; (3) explore stakeholder desires for AI-based tools; and (4) assess alignments and gaps to inform tailored AI solutions. METHODS An anonymous cross-sectional online survey of exploratory nature was distributed (from Dec. 2024 to Oct. 2025) in five languages. It was completed by 255 respondents. Descriptive statistics summarized responses to 41 questions, including stakeholder-specific items. Chi-square tests were performed to examine stakeholder differences in desired AI-features. RESULTS : Interest in predictive AI was high across stakeholder groups. Symptom-tracking was the most desired feature (selected by >76% of respondents); however, stakeholder priorities diverged in other areas. Healthcare professionals rated improving patient and informal caregiver engagement as significantly more important than PwP did, χ²(1, N=205)=34.78, p<.001, Cramer’s V=0.41. Despite considerable interest, the reported use of digital tools was limited, as most PwP did not use symptom-tracking apps or wearables, nor were they currently monitoring their condition, although many expressed intentions to begin. CONCLUSIONS While AI tools were viewed positively across groups, there were significant gaps in current usage. Stakeholder-specific preferences, including informal caregiver engagement and preventive lifestyle guidance, highlight the importance of tailored design. These findings offer early-stage insight to guide development of future AI-based solutions for PD.

  • Open Access

    Adult Proxy Online Record Access – Differences Across Four Countries

    by Maria Hägglund, Therese Scott Duncan, Josefin Hagström, Sari Kujala, Anna Dudkina, Jonas Moll, Anna Kharko, Monika A. Johansen, Charlotte Blease

    Patients’ online record access (ORA) enables patients to involve their informal caregivers in care management by sharing health information, either through proxy access functionality or informally. The European Health Data Space mandates that member countries should ensure that patients can assign a proxy to have online access to their health data. In this study, we aimed to explore the current state of proxy ORA in four countries with mature ORA implementations; Sweden, Norway, Finland, and Estonia. We identified three types of proxy ORA; full proxy ORA, no proxy ORA, and controlled proxy ORA. Further guidance on ethically sound and secure proxy ORA functionality that complies with national and EU regulations and policies is warranted to ensure equal rights for citizens across Europe.


  • Open Access

    Stakeholder Perspectives on Trustworthy AI for Parkinson Disease Management Using a Cocreation Approach: Qualitative Exploratory Study

    by Beatriz Alves, Ghada Alhussein, Sara Riggare, Therese Scott Duncan, Ali Saad, David M Lyreskog, Christos Chatzichristos, Ioannis Gerasimou, Stelios Hadjidimitriou, Leontios J Hadjileontiadis, et al.

    Background: Parkinson disease (PD) is the fastest-growing neurodegenerative disorder in the world, with prevalence expected to exceed 12 million by 2040, which poses significant health care and societal challenges. Artificial intelligence (AI) systems and wearable sensors hold potential for PD diagnosis, personalized symptom monitoring, and progression prediction. Nonetheless, ethical AI adoption requires several core principles, including user trust, transparency, fairness, and human oversight. Objective: This study aims to explore and synthesize the perspectives of diverse stakeholders, such as individuals living with PD, health care professionals, AI experts, and bioethicists. The aim was to guide the development of AI-driven digital health solutions, emphasizing transparency, data security, fairness, and bias mitigation while ensuring robust human oversight. These efforts are part of the broader Artificial Intelligence-Based Parkinson’s Disease Risk Assessment and Prognosis (AI-PROGNOSIS) European project, dedicated to advancing ethical and effective AI applications in PD diagnosis and management. Methods: An exploratory qualitative approach, based on 2 datasets constructed from cocreation workshops, engaged key stakeholders with diverse expertise to gather insights, ensuring a broad range of perspectives and enriching the thematic analysis. A total of 24 participants participated in the cocreation workshops, including 11 (46%) people with PD, 6 (25%) health care professionals, 3 (13%) AI technical experts, 1 (4%) bioethics expert, and 3 (13%) facilitators. Using a semistructured guide, key aspects of the discussion centered on trust, fairness, explainability, autonomy, and the psychological impact of AI in PD care. Results: Thematic analysis of the cocreation workshop transcripts identified 5 key main themes, each explored through various corresponding subthemes. AI trust and security (theme 1) was highlighted, focusing on data safety and the accuracy and reliability of the AI systems. AI transparency and education (theme 2) emphasized the need for educational initiatives and the importance of transparency and explainability of AI technologies. AI bias (theme 3) was identified as a critical theme, addressing issues of bias and fairness and ensuring equitable access to AI-driven health care solutions. Human oversight (theme 4) stressed the significance of AI-human collaboration and the essential role of human review in AI processes. Finally, AI’s psychological impact (theme 5) examined the emotional impact of AI on patients and how AI is perceived in the context of PD care. Conclusions: Our findings underline the importance of implementing robust security measures, developing transparent and explainable AI models, reinforcing bias mitigation and reduction strategies and equitable access to treatment, integrating human oversight, and considering the psychological impact of AI-assisted health care. These insights provide actionable guidance for developing trustworthy and effective AI-driven digital PD diagnosis and management solutions.


  • Open Access

    Co-Designing a “win-win” in Predictive AI: First Results from Interviews and Focus Groups with Persons with Parkinson’s Disease

    by Jamie Luckhaus, Sara Riggare, Anna Kharko, Charlotte Blease, Maria Hägglund, Therese Scott Duncan

    This study explored the perspectives of people with Parkinson’s disease (PwP) involved in the co-design of AI tools for PD care. The aim was to understand PwP perspectives on AI tools and identify factors influencing their engagement. A qualitative triangulation of 13 interviews and two focus groups were conducted with a panel of 14 PwPs from six European countries. Data analysis employed inductive content analysis which resulted in 3 categories. Patients emphasized the potential of AI tools to increase patient agency and improve healthcare through co-design. While AI-based medication response prediction was highly regarded, risk assessment tools were met with skepticism. Participants stressed the importance of taking into account disease complexity, individual factors, data protection, and transparency in AI model development. Participants strongly believed in the co-design process, and the value that it could bring to all parties involved in the development of the AI-based tools, ensuring the development of tools that are beneficial and trustworthy.